1 / 5

Extracorporeal Membrane Oxygenation Market

Respiratory failure may result from airflow obstruction brought on by chronic obstructive pulmonary disease (COPD). It is among the severe illnesses that kill millions of people worldwide. The World Health Organization (WHO) reports that 3.23 million people worldwide died from COPD in 2019, making it the third most common cause of death in 2022. Roughly 90% of deaths from COPD take place in low- and middle-income nations.

Akanshageete9
Download Presentation

Extracorporeal Membrane Oxygenation Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Extracorporeal Membrane Oxygenation Market

  2. 3 Market Size The extracorporeal membrane oxygenation market size is projected to reach US$ 0.74 billion by 2031 from US$ 0.58 billion in 2023. The market is expected to register a CAGR of 3.10% during 2023–2031.

  3. 7 Segments Covered • By Modality • By Application • By Age Group

  4. Key Players • Terumo Group • Medtronic Plc • MicroPort Scientific Corporation • LivaNova Plc • Nipro Medical Corporation • Eurosets S.R.L. • Getinge AB • Braile Biomedica • Fresenius Medical Care

  5. Thank You

More Related